SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (16308)3/3/1998 11:51:00 AM
From: Vector1  Read Replies (1) | Respond to of 32384
 
Henry and everyone else,
Is J&Js decision to drop the Pramlitide after spending $163m not including internal spending purely a lack of confidence in Pramelitide or is it also a ringing endorsement of Ergoset Bromocriptine.
V1